retatrutide safety trial results Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease retatrutide clinical trial retatrutide drug

The trial involved 338 participants measuring the change in body weight from baseline to 24 weeks

When selecting a GLP-1 medication for a patient with Hashimoto's thyroiditis, there is no single "best" GLP-1 agonist specifically for this population

While GLP-1 agonists are not prohibited, their use in weight-class sports raises ethical questions about artificially manipulating body weight for competitive advantage

"By shipping each release with a research brief, expanded COA data, and explicit notes on sample handling and solvent compatibility, we're making it simpler to scope experiments responsibly and compare results across time, labs, and lots." Why this release matters to investigators Research programs that evaluate energy balance, endocrine signaling, muscle and bone biology, and related mechanistic pathways often rely on a tight chain between material identity, purity, solvent behavior, storage conditions, and analytical method transfer